Used primarily in pharmaceutical research as a key intermediate in the synthesis of selective serotonin reuptake inhibitors (SSRIs) and other central nervous system (CNS) active agents. Its structural configuration allows for strong binding affinity to neurotransmitter receptors, making it valuable in developing antidepressants and antipsychotic drugs. Also explored in the design of dopamine and sigma receptor ligands for potential use in treating neurological disorders such as Parkinson’s and schizophrenia. Due to its solubility and stability, it is suitable for formulation development in early-stage drug discovery.